Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 2.48 MYR
Change Today 0.00 / 0.00%
Volume 16.8K
CCMD On Other Exchanges
Symbol
Exchange
Kuala Lumpur
As of 12:09 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

ccm duopharma biotech bhd (CCMD) Snapshot

Open
2.48
Previous Close
2.48
Day High
2.48
Day Low
2.48
52 Week High
05/21/15 - 3.04
52 Week Low
12/31/14 - 1.78
Market Cap
691.8M
Average Volume 10 Days
68.2K
EPS TTM
0.20
Shares Outstanding
279.0M
EX-Date
10/13/15
P/E TM
12.7x
Dividend
0.15
Dividend Yield
5.53%
Current Stock Chart for CCM DUOPHARMA BIOTECH BHD (CCMD)

Related News

No related news articles were found.

ccm duopharma biotech bhd (CCMD) Related Businessweek News

No Related Businessweek News Found

ccm duopharma biotech bhd (CCMD) Details

CCM Duopharma Biotech Berhad, an investment holding company, manufactures, distributes, imports, and exports pharmaceutical products and medicines in Malaysia. It offers various over the counter products, such as analgesic/anti-pyretics, children’s vitamins, cough preparations, dermatology products, eye drops, first aid dressings, health supplements, and pain relievers, and hand sanitizers. The company offers its products in various forms, including tablets, capsules, syrups, oral antibiotics, creams, haemodialysis solutions, sterile irrigation solutions, sterile powder injectables, small volume injectables, dental cartridges, and eye drop preparations. It exports its products to Vietnam, Ethiopia, Sudan, South East Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore, and Hong Kong. The company was founded in 1979 and is based in Klang, Malaysia. CCM Duopharma Biotech Berhad is a subsidiary of CCM Marketing Sdn. Bhd.

478 Employees
Last Reported Date: 04/30/15
Founded in 1979

ccm duopharma biotech bhd (CCMD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ccm duopharma biotech bhd (CCMD) Key Developments

CCM Duopharma Biotech Berhad Declares Interim Single Tier Dividend for the Fiscal Year Ending December 2015, Payable on November 6, 2015

CCM Duopharma Biotech Berhad announced interim single tier dividend of 4 sen per ordinary share for the fiscal year ending December 2015, payable on November 6, 2015, ex-date on October 13, 2015 and entitlement date on October 16, 2015.

CCM Duopharma Biotech Berhad Reports Unaudited Consolidated Earnings Results for the Second Quarter and Year to Date Ended June 30, 2015

CCM Duopharma Biotech Berhad reported unaudited consolidated earnings results for the second quarter and year to date ended June 30, 2015. For the company reported revenue of MYR 56.308 million against MYR 40.623 million a year ago. Profit before tax was MYR 8.407 million against MYR 10.107 million a year ago. Profit attributable to ordinary equity holders of the parent was MYR 5.848 million or 4.19 sen per diluted share against MYR 7.513 million or 5.41 sen per diluted share a year ago. Profit from operations was MYR 8.593 million against MYR 10.295 million a year ago. The increase in revenue was mainly due to revenue contribution of MYR 13.07 million from the newly acquired subsidiary companies with effect from 01/06/2015. Excluding the newly acquired subsidiary companies' contribution, current quarter revenue has decreased by 5.1% as compared to preceding quarter as customers had increased their purchases in the preceding quarter ahead of the implementation of Goods & Services Tax (GST). Current quarter PBT was also impacted by costs associated to unionised staff upon signing of Collective Agreement. For the year to date, the company reported revenue of MYR 101.907 million against MYR 81.118 million a year ago. Profit before tax was MYR 20.605 million against MYR 21.302 million a year ago. Profit attributable to ordinary equity holders of the parent was MYR 14.817 million or 10.59 per diluted share against MYR 15.892 million or 11.45 per diluted share a year ago. Profit from operations was MYR 20.752 million against MYR 21.403 million a year ago. Net cash used in operating activities was MYR 91.261 million against net cash generated from operating activities of MYR 3.542 million a year ago. Acquisition of property, plant and equipment was MYR 11.410 million against MYR 6.876 million a year ago.

CCM Duopharma Biotech Berhad to Invest Up to MYR 70 Million in Civil Infrastructure

CCM Duopharma Biotech Bhd (CCMD) will invest between MYR 40 million to MYR 70 million in civl infrastructure including for a new factory in Klang which will enable it to grow production capacity to three billion tablets a year from two billion tablets currently.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCMD:MK 2.48 MYR 0.00

CCMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CCMD.
View Industry Companies
 

Industry Analysis

CCMD

Industry Average

Valuation CCMD Industry Range
Price/Earnings 9.1x
Price/Sales 1.6x
Price/Book 1.6x
Price/Cash Flow 18.1x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CCM DUOPHARMA BIOTECH BHD, please visit www.duopharma.com.my. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.